Work

Interpreting Section 19A Dispensing Shares During Methylphenidate Shortages

Year: 2026

Type: article

Abstract: The data that support the findings of this study are available in Pharmaceutical Benefits Scheme (PBS), Australian Government at https://www.pbs.gov.au/statistics/dos-and-dop/dos-and-dop. These data were derived from the following resources available in the public domain: PBS and RPBS Date of Supply Data: Quarterly Date of Supply Supplementary Report, July 2025 - June 2026, https://www.pbs.gov.au/statistics/dos-and-dop/files/dos-jul-2025-to-jun-2026-phrmcy-type.csv; PBS Item Code to Drug Mapping File (September 2026 release), https://www.pbs.gov.au/statistics/dos-and-dop/files/pbs-item-drug-map.csv.

Source: Pharmacoepidemiology and Drug Safety

DOI: 10.1002/pds.70514

Author: Liu Yutong

Institutions: Shanghai University of Traditional Chinese Medicine, Shanghai University of Medicine and Health Sciences

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $4,650